Gopinath Subash Chandra Bose
National Institute of Advanced Industrial Science and Technology, Ibaraki, Japan.
Thromb Res. 2008;122(6):838-47. doi: 10.1016/j.thromres.2007.10.022. Epub 2007 Dec 4.
In the past decade development of aptamer technology is poised into several fields with various clinical applications. With this progress, aptamer based anti-coagulant agents are evolved and continuing their applications with clinical trials. At present several anti-coagulant aptamers are available against different proteins from blood coagulation cascade. In this review, the mechanism and functions of anti-coagulant aptamers, as an alternate candidate to other available anti-coagulant agents are discussed.
在过去十年中,适配体技术已进入多个领域并具有各种临床应用。随着这一进展,基于适配体的抗凝血剂不断发展,并在临床试验中持续应用。目前,有几种抗凝血适配体可针对凝血级联反应中的不同蛋白质。在这篇综述中,我们讨论了抗凝血适配体作为其他现有抗凝血剂的替代候选物的作用机制和功能。